Abstract
e18055 Background: Although patients achieve complete cytogenetic response (CCyR) under tyrosine kinase inhibitors (TKIs) in Chronic MyeloidLeukemia (CML), bcr-abl gene positive cells can still be ...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
